Skip to main content
Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
183.38
+2.71 (1.50%)
At close: Apr 28, 2026, 4:00 PM EDT
184.88
+1.50 (0.82%)
Pre-market: Apr 29, 2026, 7:11 AM EDT

Biogen Revenue

In the year 2025, Biogen had annual revenue of $9.89B with 2.22% growth. Biogen had revenue of $2.28B in the quarter ending December 31, 2025, a decrease of -7.14%.

Revenue (ttm)
$9.89B
Revenue Growth
+2.22%
P/S Ratio
2.72
Revenue / Employee
$1,318,747
Employees
7,500
Market Cap
26.91B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20259.89B214.70M2.22%
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck & Co. 65.01B
Pfizer 62.58B
Novartis AG 56.58B
Sanofi 54.60B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
GSK plc 43.29B
Amgen 36.75B
Revenue Rankings

BIIB News

More News